Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones
Status:
Not yet recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
Small exploratory open-label pilot study to assess supplementation of a ketone ester
(KetoneAid) as a potential therapy for persons with Parkinson disease (PD), Parkinson Disease
Dementia/Lewy Body Dementia (PDD/LBD), and healthy controls.